Opportunities for Electroceuticals in Epilepsy

Abstract

Epilepsy is a neurological disorder that affects ∼1% of the world population. Nearly 30% of epilepsy patients suffer from pharmacoresistant epilepsy that cannot be treated with antiepileptic drugs. Depending on seizure type, a diverse range of therapies are available, including surgery, vagus nerve stimulation, and deep brain stimulation. We review the sensing and stimulation technologies most used in neurological disorders, and provide a vision of minimally invasive electroceuticals to enable accurate forecasting of epileptic seizures and therapy. The use of such systems could potentially help patients to prevent injuries and, in combination with an intervention mechanism, could provide a method of suppressing seizures in epileptic patients.

Keywords: artificial intelligence; electroceuticals; epilepsy; microelectronics.